cdmo.directory
← Compare landing

Biomay AG vs eXmoor Pharma

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBiomay AGeXmoor Pharma
SummaryGMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.
Services
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Viral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • mRNA
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Formulation development
  • Analytical method development
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Expression: Mammalian
  • Expression: Microbial
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Single-Use / Disposable
Locations
  • Headquarters, Vienna, Austria
  • Headquarters
Certifications
  • EMA · Identifier: GMP
Data not yet provided.

Find similar companies

Biomay AG alternatives · eXmoor Pharma alternatives

Markdown mirror: /compare/biomay/exmoorpharma.md